$TLI in refractory chronic GVHD$

TLI in refractory chronic GVHD

Refractory chronic GVHD (cGVHD) remains a major cause of morbidity after transplantation. Many drugs are used but there is no consensus on the standard of care. We investigated the efficacy of TLI in corticosteroid-refractory cGVHD. We analyzed retrospectively 31 patients receiving one or more TLI s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2013-06, Vol.48 (6), p.854-858
Hauptverfasser:	Devillier, R, Castagna, L, Gonzague, L, El-Cheikh, J, Fürst, S, Faucher, C, Michel, R, Blaise, D
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/1904 631/532/1542 692/699/249/1529 692/700/565/251/1574 Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - adverse effects Adult Allografts Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Chronic Disease Corticosteroids Disease-Free Survival Drug Resistance - drug effects Drug Resistance - radiation effects Drug therapy Drugs Female Follow-Up Studies Graft versus host reaction Graft vs Host Disease - mortality Graft vs Host Disease - therapy Health aspects Hematology Hematopoietic stem cells Humans Immunosuppressive agents Immunosuppressive Agents - administration & dosage Internal Medicine Male Medical sciences Medicine Medicine & Public Health Middle Aged Morbidity Neoplasms - mortality Neoplasms - therapy original-article Patients Public Health Response rates Risk factors Stem Cell Transplantation Stem Cells Steroids Survival Rate Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!